Its efficacy in lowering hemoglobin A1c levelsa marker of average blood glucose over the past two to three monthshas been well documented in clinical trials, showcasing its superiority over other antidiabetic agents in certain cases
655 Omega-3 supplementation: In a single-arm, open-label trial of seal oil -3 PUFA supplementation (composed of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid) for 1 year in patients with T1DM and diabetic sensorimotor polyneuropathy, a 29% improvement in the primary endpoint of corneal nerve fiber length was observed
Due to the excessive secretion of cytokines during this process, metabolic activities increase rapidly, leading to a hypoxic microenvironment
[4] These findings are limited to the rat strain, exposure protocol, controls, endpoints, and analytical methods described in that study